The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...

Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...

The Bosma Visionary Opportunities Foundation will host its annual fundraising gala, Dining in the Dark, on Saturday, ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

The utility and Lebanon plan to fund the six-year project with loans low-interest from Indiana’s Drinking Water State ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced the FDA approval of its new biologic treatment, EBGLYSS™ (lebrikizumab-lbkz), for patients 12 years and older... ByInvesting.com ...